Reporter Gene Assay Market - Emerging Industry Trends & Global Future Forecasts

The major factors driving the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and a rising preference for cell-based assays.

The report “Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024", The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2019, at a CAGR of 10.1%.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

By application, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period (2019-2024)”

Based on application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. In 2019, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to its importance in several cellular functionalities (such as cell differentiation, cell fate determination, and cell growth) and advanced applications of cell signaling in life science sectors (such as biotechnology, molecular biology, and microbiology).

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20053198

Recent Developments:

# In 2018, Thermo Fisher acquired Advanced Bioprocessing business from BD, to expand Thermo Fisher Scientific’s cell-culture media products and strong technical services program.

# In 2017, Becton, Dickinson and Company acquired C.R Bard (US). This acquisition advanced BD’s product offerings and global reach.

# In 2018, Merck opened a new 3,800-square-meter laboratory in Singapore.

# In 2018, Thermo Fisher Scientific (US) opened its Bioprocess design center in Shanghai.

By product, the Assay kits segment to dominate the reporter gene assays market in 2019

On the basis of product, the market is broadly split into reagents and assay kits. The assay kits segment is expected to account for the larger share of the reporter gene assays market in 2019. The large share of the assay kits segment can be attributed to their repeated use in gene expression studies and signaling pathway analysis during gene transcription or translation levels. Assay kits are preferred over standalone reagents in cases where a validated protocol for assay development is available. Assay kits not only save time but also offer technological advantages, easy availability, and greater convenience.

Critical questions the report answers:

# Where will all these developments take the industry in the mid-to-long term?

# What are the major end users of reporter gene assays?

# What are the application areas of the reporter gene assays?

# Which are the most commonly used reporter gene assays kits?

# What is the global scenario of the reporter gene assays market?

North America to hold the largest regional market share in 2019

North America is expected to account for the largest share of the reporter gene assays market in 2019, followed by Europe. The large share of North America in the global market can be attributed to the growing academic and government investments in genomics and proteomics research; rising demand for cell-based assays in research; increasing focus on cell-based therapeutics; and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=20053198

The prominent players in the reporter gene assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US).

Surgical Imaging Industry: Major Leaders & Their Contribution in Global Growth

The following are the major objectives of the study:

# To describe and forecast the Surgical Imaging Market, in terms of value, by technology, application, and region.

# To describe and forecast the market, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries.

# To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To study the complete value chain of surgical imaging.

# To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the surgical imaging ecosystem.

# To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing competitive landscape for market leaders.

# To analyze strategic approaches such as partnerships, agreements, alliances, collaborations, product launches, expansions, and acquisitions in the market.

GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the surgical imaging market.

Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India).

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210534462

Agreements, collaborations, alliances, and partnerships were the key strategies adopted by players from 2014–2017. 

The players that adopted these strategies are Koninklijke Philips, Ziehm Imaging, GE Healthcare, Siemens, OrthoScan, Toshiba Medical Systems, and Medtronic. Koninklijke Philips accounted for a share of 38% of the total number of agreements, collaborations, alliances, and partnerships in the surgical imaging market. This high share of the company can be attributed to its increasing number of partnerships and collaborations with hospitals which are the primary end users of C-arms.

Target Audience:

# C-arms manufacturers and distributors

# Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)

# Medical device vendors/service providers

# Research institutes

# Niche companies manufacturing imaging systems

# Research and consulting firms

# Venture capitalists

GE Healthcare held the first position in the global surgical imaging market in 2016. Its leading position in the market is attributed to the highest number of installed systems and its wide and diverse platform of mobile C-arms. The company’s product portfolio of mobile C-arm includes OEC 9900 Elite, its flagship product. The OEC 9900 Elite provides improved image quality and optimal dose management which improves patient care. The product portfolio also includes OEC Brivio 865 Advance which was developed as an affordable option for orthopedic surgical imaging. The strong, wide, and diversified portfolio of mobile C-arms is an asset to the company.

Siemens acquired the second largest share of the global surgical imaging market in 2016. The company offers a comprehensive range of mobile C-arms. To maintain its leading position and increase its customer base in the surgical imaging market, the company mainly focuses on strategic partnerships with hospitals and other healthcare organizations. From 2014 to 2017, the company has partnered with many hospitals in the US, the UK, India, and Chile to offer its services and imaging systems.

Critical questions the report answers:

# Where will all these developments take the industry in the mid to long term?

# What are the upcoming industry applications for surgical imaging?

Advantages of FPDs over image intensifiers

The evolution of C-arms-from the traditional X-ray image intensifier technology to digital flat-panel detectors (FPDs)-has brought about significant advancements in diagnostic imaging. FPDs have a number of advantages over image intensifiers, such as compact size and reduced radiation dose. Although resolution varies from model to model, FPDs have the ability to produce a more consistent high-quality digital image.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=210534462

North America to dominate the market in 2017

North America is expected to account for the largest share of the surgical imaging market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.

Brain Monitoring Market - Emerging Trends | Future Forecasts | Global Leaders

Recent Developments in Global Brain Monitoring Industry:

# In October 2017, Natus Medical (US) acquired Integra LifeSciences (Neurosurgery Assets) (US). As part of the transaction, Natus acquired the global Camino ICP monitoring product line, including its San Diego manufacturing facility, from Integra. The sale also includes the US rights relating to Integra’s fixed pressure shunts, as well as US rights to Codman’s DURAFORM dural graft implants, standard EVD catheters, and CSF collection systems.

# In March 2016, Natus Medical acquired NeuroQuest, a provider of neurodiagnostic services. This acquisition complemented its otherwise organic growth strategies and enabled the company to strengthen its brand and establish itself as a leading player in the ambulatory EEG service business.

This market is projected to reach USD 11.6 billion by 2024 from USD 8.7 billion in 2019, at a CAGR of 6.1% during the forecast period.

The increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative disorders, growing incidence of traumatic brain injuries, and the increasing applications of brain monitoring in clinical trials are driving the growth of this market. On the other hand, factors like the dearth of trained professionals to effectively operate brain monitoring devices and unfavorable reimbursement policies are restraining the growth of this market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=909

Key Questions Addressed by the Report

# Where will all these developments take the industry in the mid- to long-term?

# What types of annual and multi-year partnerships are brain monitoring companies exploring?

# Who are the key players in the market, and how intense is the competition?

# Which are the recent contracts and agreements key players have signed?

# What are the recent trends affecting the brain monitoring market?

Major Growth Driver: Growing incidence of traumatic brain injuries

A traumatic brain injury (TBI) is non-degenerative, non-congenital damage to the brain from an external mechanical force, possibly leading to permanent or temporary impairment. TBI is a major public health concern, and the most common cause of death and disability in developed as well as developing countries.

Opportunity: Increasing Expanding therapeutic applications of brain monitoring devices

Apart from applications in neurological disorders, neurodegenerative diseases, and psychiatric disorders, brain monitoring devices are also used in other therapeutic areas like insomnia, post-traumatic stress disorder (PTSD), and sleep apnea. Quantitative EEG analysis is widely used to investigate the neurophysiological characteristics of insomnia. EEG biofeedback is a training process that has been scientifically proven to aid in the management of PTSD.

“North America is expected to command the largest share of the brain monitoring market in 2019.”

On the basis of region, the global brain monitoring market is divided into North America, Europe, Asia, and the RoW. North America is expected to hold the largest share of the global brain monitoring market in 2019, while Asia is projected to be the fastest-growing region in the forecast period. Growth in the market in Asia can be attributed to the growing geriatric population, the availability of low-cost labor and skilled manpower, increase in disposable incomes, rising prevalence of neurodegenerative disorders, and increasing government emphasis on healthcare reforms in the region.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=909

Major Leaders:

The brain monitoring market is a highly diversified and competitive market, with a large number of players, including mid-tier companies and startup firms, competing for market shares. These players have adopted various growth strategies, such as product launches, expansions, acquisitions, and collaborations & agreements, to further expand their presence in the market.

The prominent players in the brain monitoring market are Advanced Brain Monitoring (US), Nihon Kohden Corporation (Japan), Natus Medical, Inc. (US), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Masimo Corporation (US), Spiegelberg GmbH & Co. KG (Germany), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), Neurosoft (Russia), and Rimed (US).

Liquid Handling System Market - Expected Global Industry Growth by 2022

The objectives of this study are as follows:

# To define, describe, and forecast the Liquid Handling System Market on the basis of type, product, application, end user, and region.

# To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders.

# To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW).

# To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies.

# To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the liquid handling systems market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192124302

Electronic systems are estimated to command the largest market share in 2017

The liquid handling systems market is segmented by type into electronic systems, automated systems, and manual systems. In 2017, the electronic systems segment is expected to account for the largest share of the liquid handling systems market, by type. High accuracy and reproducibility offered by electronic liquid handling systems, coupled with their lower cost compared to automated systems are factors driving its adoption among end users like pharmaceutical and biotechnology companies, research laboratories, and academic institutes.

Pipettes are estimated to dominate the market in 2017

On the basis of products, the liquid handling systems market is segmented into pipettes, burettes, consumables, microplate reagent dispensers, microplate washers, liquid handling workstations, software, and other products. The pipettes segment is expected to dominate the global liquid handling systems market in 2017. Efficient performance, reliability, great level of precision, adaptability across multiple applications, and minimal maintenance needs are key drivers increasing the demand for pipettes.

Target Audience for this Report:

# Genomics and proteomics associations

# Drug discovery and development research centers

# Hospitals and diagnostic laboratories

# Research & consulting firms

# Distributors of liquid handling products

# Contract manufacturers of protein liquid handling systems and consumables

# Research institutes and clinical research organizations (CROs)

# Venture capitalists

# Government associations

North America expected to account for the major share of the market in 2017

Based on region, the liquid handling systems market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the liquid handling systems market in 2017 on account of growth in the biotechnology and pharmaceutical industries, rising prevalence of chronic diseases, and higher investments in genomics and proteomics research in the region.

The key strategy followed by most companies in the liquid handling systems market are product launches. This strategy accounted for the largest share of the overall growth strategies mapped from 2015 to 2017.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=192124302

Key players in the liquid handling systems market include Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Tecan Group Ltd. (Switzerland), Gardner Denver Medical (Germany), Mettler-Toledo International Inc. (U.S.), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Sartorius AG (Germany), Corning Incorporated (U.S.), Gilson, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Qiagen N.V. (Germany), Lonza Group Ltd (Switzerland), Brooks Automation, Inc. (U.S.), Integra Holding AG (Switzerland), Endress+Hauser AG (Switzerland), Labcyte Inc. (U.S.), BioTek Instruments, Inc. (U.S.), TTP Labtech Ltd (U.K.), Metrohm AG (Switzerland), BRAND GMBH + CO KG (Germany), Tomtec, Inc. (U.S.), Hudson Robotics, Inc. (U.S.), and Orochem Technologies Inc. (U.S.).

European Medical Equipment Maintenance Market - Reasons Behind Major Industry Growth

The objectives of this study are as follows:

# To define, describe, and forecast the European medical equipment maintenance market by device, service, service provider, contract type, end user, and country.

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the size of the market segments with respect to European countries, namely, Germany, Italy, U.K., France, Spain, and Rest of Europe (RoE).

# To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies.

# To track and analyze competitive developments such as agreements, partnerships, collaborations, mergers & acquisitions, and expansions in the European medical equipment maintenance market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243039217

This market is expected to reach USD 8.93 Billion by 2022 from USD 6.64 Billion in 2017, at a CAGR of 6.1% during the forecast period.

The growth of the market is attributed to rising focus on preventive maintenance. Preventive maintenance is gaining prominence as planned inspections and medical device maintenance help avoid adverse incidents and medical-device related accidents.

Regular maintenance services provided by OEMs, ISOs, or in-house service technicians ensure safe, efficient, and long-lasting use of medical devices. The growing focus on implementing preventive maintenance strategies among healthcare organizations is expected to offer growth opportunities for service providers in the coming years. 

Target Audience for this Report:

# Medical equipment manufacturers and suppliers

# Independent services organizations (ISOs)

# Healthcare institutions (hospitals and outpatient clinics)

# Academic institutes and universities

# Distributors and suppliers of electromedical equipment and services

# Research and consulting firms

On the basis of end user, private-sector organizations are to grow at the highest CAGR within the forecast period

By end user, the European medical equipment maintenance market is segmented into public sector organizations and private-sector organizations. In 2017, private-sector organizations are expected to register the highest CAGR during the forecast period. The increasing number of public- private partnerships is expected to boost the demand for medical equipment maintenance services in Europe.

Germany to dominate the market followed by Italy

By region, the European medical equipment maintenance market is segmented into Germany, Italy, UK, France, Spain, and RoE. In 2017, Germany accounted for the largest share of the market; this regional segment is also expected to grow at highest CAGR during the forecast period, followed by Italy. The high growth of the German market is attributed to the factors such as the significant presence of OEMs, growing medical technology market, well-established healthcare infrastructure and large installation base of medical equipment. Italy is the second largest growing market, factors such as focus on value-based healthcare system, and strategic expansion of market players, are expected to fuel the market growth in this country.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=243039217

Partnerships, collaborations and agreements were the key growth strategies adopted by the market players to maintain and improve their position in the European medical equipment maintenance market.

Mergers & acquisitions accounted for the second largest share of the overall growth strategy mapped from 2014-2017. Some of the leading players who adopted this strategy include Hitachi, Ltd. (Japan), Medtronic plc (Ireland), and Pantheon Healthcare Group (Italy).

The medical equipment maintenance market is highly competitive with several big and small players. The market, however, is dominated by the OEMs. Prominent OEMS in the medical equipment maintenance market include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), and Drägerwerk AG & Co. KGaA (Germany); whereas, TBS Group S.p.A. (Italy), Pantheon Group (Italy), Technologie Sanitarie S.p.A. (Italy), Avensys UK Ltd. (U.K.), and Grupo Empresarial Electromédico (Spain) are some leading ISOs operating in the market.

Proteomics Research Industry is Expecting Major Surge in Global Revenue in Near Future

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives of the Study:

# To define, describe, segment, and forecast the global Proteomics Market by instrumentation technology, reagent, services and software, application, end user, and region

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

The use of immunoassay reagents is increasing with the rising need for precise protein identification

Based on reagent, the proteomics market is segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents segment is estimated to account for the largest market share in 2018, mainly due to the ability to quickly and easily provide precise and accurate results for protein identification and separation, which form the initial steps for proteome analysis.

Critical questions the report answers:

# Where will all these developments take the industry in the long term?

# What are the upcoming trends in the proteomics market?

# Which segment provides the most opportunity for growth?

# Who are the leading vendors operating in this market?

# What are the opportunities for new market entrants?

By instrumentation technology, the spectroscopy segment is expected to account for the largest share of the proteomics market

The proteomics market, by instrumentation technology, is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The spectroscopy segment accounted for the largest market share in 2018. The ability of spectroscopy to quantify the complex structure of proteins on a large scale and its capability to integrate with other technologies for protein quantification make spectroscopy an indispensable tool in proteomics. This contributes to the large share of the segment.

Recent Developments:

# In October 2018, Waters Corporation launched its RenataDX Screening System.

# In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer.

# In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.

# In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

North America to dominate the proteomics market during the forecast period

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Key Market Players

# Thermo Fisher Scientific, Inc. (US)

# Agilent Technologies, Inc. (US)

# Danaher Corporation (US)

# Merck KGaA (Germany)

# Waters Corporation (US)

North American Healthcare IT Market - Global Monetary Growth Expectations | Industry Dynamics

The study involved four major activities in estimating the size of the North America Healthcare IT Market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their trends at the country level. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product and services, components, and end user). After that, market breakdown and data triangulation methods were used to estimate the size of segments and subsegments.

The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4% during the forecast period.

A majority of this growth is attributed to the growing adoption of various healthcare IT solutions by providers to meet the heightened regulatory requirements for patient care and safety, increasing need to curtail soaring healthcare costs, and growing need to improve the quality of healthcare while maintaining the operational efficiency of healthcare organizations.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1190

Major Objectives of This Study:

# To define, describe, and forecast the North America healthcare IT market with respect to product & services, application, technology, end-user, and country segments.

# To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall North America healthcare IT market.

# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the size of the North America healthcare IT market for three countries: US, Canada, and Mexico.

# To profile the key players in the North America healthcare IT market and comprehensively analyze their core competencies.

# To track and analyze competitive developments such as acquisitions, new tests/technology developments, geographical expansions, and research & development activities of the leading players in the North America healthcare IT market.

By end-users, the healthcare providers segment accounted for the largest share of the North America healthcare IT market in 2018

Based on end-users, the North American healthcare IT market is segmented into healthcare providers and healthcare payers. The healthcare providers segment is divided further into hospitals; ambulatory care centers; home healthcare agencies, nursing homes, and assisted living facilities; diagnostic and imaging centers; and pharmacies.

The healthcare payers segment is divided further into private payers and public payers. Hospitals form the largest end-user segment of the North American healthcare IT market, owing to the huge demand for various HCIT solutions among hospitals to manage the increasing load of patient information generated in hospitals and growing need to improve the quality of healthcare while improving operational efficiencies within organizations.

Target Audience:

# North American healthcare IT manufacturers

# North American healthcare IT distributors

# Healthcare payer companies

# Government associations

# Market research and consulting firms

# Venture capitalists and investors

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=1190

North America will continue to dominate the North America healthcare IT market during the forecast period

The market, by country, is segmented into the US, Canada, and Mexico. US accounted for the largest share of the North America healthcare IT industry in 2018 due to stringent legislative and accreditation requirements regarding healthcare, high adoption rate of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of IT companies, such as EPIC Systems (U.S.), Cerner Corporation (U.S.), McKesson Corporation (U.S.), Infor, Inc. (U.S.), and Allscripts Healthcare Solutions, Inc.

Recent Developments:

# In 2019, Cerner Corporation launched the Next-generation cognitive health platform.

# In 2019, GE Healthcare launched Edison Datalogue and my.Cryochain software.

# In 2019, Cerner Corporation collaborated with Uniform Data System for Medical Rehabilitation to integrate their solutions that would help improve workflow for inpatient rehabilitation facilities.

# In 2019, Epic Systems partnered with Teledoc Health to integrate Teledoc Health’s virtual care platform to Epic’s App Orchard that would help the company conduct telehealth video visits.

Some of the prominent players operating in the North America healthcare IT market are McKesson Corporation (US), Oracle Corporation (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Athenahealth, Inc. (US), Infor, Inc. (US), Cognizant (US), Dell Technologies (US), and CVS Health (US).

Development and Use of Advanced Filters Brings Out a Major Paradigm Shift in Global Sterile Filtration Market

The study involved two major activities in estimating the current market size of the sterile filtration market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Data Triangulation:

After arriving at the overall market size-using the market size estimation processes explained above-the market was split into several segments and subsegments.

To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256410424

The major factors driving the growth of this market include the advantages of sterile filters over non-sterile filters, the growing demand for pure water in the end-user market, increasing adoption of single-use technologies, and rising focus on the development of large biopharmaceutical drugs.

The sterile filtration market is projected to reach USD 7.4 billion by 2025 from USD 4.7 billion in 2019, at a CAGR of 8.0% during the forecast period.

Fill-finish process accounted for the largest share of the application segment in 2018

Based on application, the sterile filtration market is segmented into fill-finish processes, buffer filtration & cell culture media preparation, bioburden reduction, water purification, and air filtration. The fill-finish processes segment accounted for the largest market share in 2018. The fill-finish process is the final operation in the manufacturing of sterile products and demands the highest level of quality and reliability. This, in turn, drives the demand for sterile filters, as it is the most critical filtration step to ensure product sterility and safety.

Recent developments:

# In 2019, Merck (Germany) launched the Stericup Quick Release 500 ml Vacuum Filtration System.

# In 2019, Merck (Germany)) expanded its distribution capacity in Gillingham, UK.

# In 2019, Sartorius (Germany) launched Sartolab MultiStation (filtration units).

# In 2018, Pall (US) established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China. This center is equipped with advanced bioprocessing equipment, including single-use cell culture solutions, cell clarification using acoustic wave technology, chromatography using automated packing techniques, viral clearance, and tangential flow filtration, to serve bioprocess engineering consultancies for China and broader Asia.

North America accounted for the largest share of the sterile filtration market in 2018

The large share of North America in this market is attributed to factors such as the strong presence of sterile filter product manufacturers in the region, the presence of a well-established biopharmaceutical industry, significant R&D spending by pharmaceutical and biotechnology companies, and the presence of a well-established intellectual property system for innovative biologics production.

Key questions addressed by the report:

# Who are the major market players in the sterile filtration market?

# What are the regional growth trends and the largest revenue-generating regions in the market?

# What are the major drivers and challenges in the market?

# What are the major product segments of the market?

# What are the major end users for sterile filtration?

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=256410424

The major players in the sterile filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), and Parker Hannifin Corporation (US). These players have adopted various growth strategies such as product launches, acquisitions, agreements, partnerships, and expansions to increase their presence in the global sterile filtration market.

Merck KGaA (Germany) is the leading player in the global sterile filtration market. The company offers a wide range of sterile filtration products through its Process Solutions business segment. The Process Solutions segment of the company is the most dynamic business unit; wherein in 2018, it contributed the largest share (~40%) to the company’s organic sales and witnessed double-digit growth (~16%) from the previous year.

Danaher (US) is the second-largest player in the global sterile filtration market. Danaher provides filtration, separation, and purification technologies for the medical, biopharmaceutical, and food & beverage industries through its subsidiary, Pall Corporation (a part of the Life Sciences business). Danaher operates as one of the top players in the sterile filtration market with its strong portfolio of sterile filters, inclusive of membranes, syringe filters, vacuum devices, and large-molecular capsules.

Bioprocess Validation - Emerging Industry Trends and Global Future Forecasts

This study involved the extensive use of primary and secondary sources and involved an in-depth analysis of the various factors affecting the growth of the global bioprocess validation market.

Both primary and secondary research was used to identify the segmentation types, trends, key players, key market dynamics, and key player strategies as well as derive the competitive leadership mapping and competitive landscape in this market.

The report “Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) - Global Forecast to 2024", is exceeded USD 180 million in 2019 and is projected to be valued over USD 360 million by 2024, at a CAGR of 14.6% during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39981433

The stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries, high demand for the outsourcing of bioprocess validation services and rising R&D spending in the life science are some of the major factors that are expected to drive the growth of this market during the forecast period. Additionally, automation in bioprocess validation services and geographic expansions by market players are the upcoming trends in bioprocess validation, which also expected to support market growth in the coming years.

Recent Developments

# In August 2018, Merck KGaA launched the BioReliance Product Characterization Portfolio to enhance its service portfolio in the bioprocess validation market.

# In March 2017, Toxikon and SG Lab (Italy) entered into a partnership, to extend its analytical and extractable & leachable testing service portfolio to determine the drug integrity in the entire life cycle.

# In January 2019, SGS acquired LeanSis Expertos en Productividad S.L. (Spain). This acquisition provided SGS operational and manufacturing training and capacity building services to over 200 clients across Spain.

# In February 2018, Pall Corporation expanded its Hoegaarden office in Belgium with new R&D center, customer demonstration labs, and manufacturing space. This will help the company to establish its position in the Belgium market.

North America is estimated to be the largest regional market for bioprocess validation

North America is expected to account for the largest share of the bioprocess validation market in 2019, closely followed by Europe. Factors such as the presence of well-established biopharmaceutical industry in the region, high R&D expenditure, presence of leading bioprocess validation service providers, and stringent regulatory requirements for biopharmaceutical production are driving the growth of the bioprocess validation market in North America.

Critical questions the report answers:

# Where will all these developments take the industry in the medium-to-long-term?

# What are the major trends in bioprocess validation?

# Who are the major end-users of bioprocess validation?

# Which test types are used mainly for bioprocess validation?

# Which process component has a higher adoption rate of bioprocess validation?

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=39981433

The prominent players operating in the bioprocess validation market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).

Merck KGaA, Sartorius Stedim Biotech, and Pall Corporation are the Leading Players in the Bioprocess Validation Market

Rheometer & Viscometer Market - This is How COVID19 Impacted Global Revenue & Industry Growth

Objectives of This Study:

# Covid Impact on Rheometer & Viscometer Market, growth/decline in product type/use cases of Rheometer & Viscometer Market due to cascaded impact of Covid on Extended Ecosystem..

# How top 50 companies in Rheometer & Viscometer Market are making rapid shifts in their strategies as we speak here.

# Outside-in view of top 50 companies client and client’s clients shifting short-term priorities

The report studies the global rheometers and viscometers market over the forecast period from 2018 to 2023. The market is projected to reach USD 878.6 million by 2023 from USD 721.5 million in 2018, at a CAGR of 4.0%.

The demand for rheometers and viscometers across key markets is majorly driven by factors such as technology advancements; expansion of petrochemical and material manufacturing industries; growing stringency of the regulatory framework for product safety compliance in cosmeceutical, biotechnology, and pharmaceutical industries; rising public-private investments to support product innovation; and increasing burden of target diseases, globally.

However, the high cost of viscometers and rheometers is expected to restrain the growth of this market during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93584044

Based on end user, the petroleum product manufacturers & petrochemical refineries segment is expected to account for the largest share of this market in 2018.

On the basis of end user, the rheometers and viscometers market is categorized into petroleum product manufacturers & petrochemical refineries; pharmaceutical, cosmeceutical, and biotechnology companies; chemical and material manufacturers; food and beverage manufacturers; research laboratories and academic institutes, and other end users. Petroleum product manufacturers & petrochemical refineries are expected to account for the largest share of the rheometers and viscometers market in 2018. 

The mandatory rheological evaluations for product quality assessment as regulatory guidelines across respective countries and the rising production output & capabilities of major product manufacturers are the key factors supporting the growth of the rheometers and viscometers market for petroleum product manufacturers & petrochemical refineries.

North America is expected to dominate the rheometers and viscometers market in 2018.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The large share of North America can be attributed to ongoing technological advancements in the field of rheometers & viscometers, the wide availability of rheometers and viscometers in the region (owing to the strong distribution networks of major product manufacturers in North America), and the strong presence of major device manufacturers.

Analysis of the market developments between 2014 and 2018 reveals that several growth strategies, such as product launches, expansions, mergers, and agreements were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the rheometers and viscometers market. Among these business strategies, product launches and market expansions were the most widely adopted growth strategies by players in the market.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=93584044

Global Stakeholders:

# Rheometer and viscometer manufacturing companies

# Pharmaceutical, biotechnology, and cosmeceutical companies

# Petroleum manufacturers and petrochemical refineries

# Food processing companies and beverage manufacturers

# Chemical and material manufacturers

# Environmental testing, food testing, and forensic analysis laboratories

# Product sales and distribution companies

# Research and development companies

# Research laboratories and academic institutes

# Clinical research organizations (CROs)

# Government and non-governmental regulatory authorities

# Independent national and international associations

# Diagnostic and forensic testing laboratories

# Market research and consulting firms

Gene Panel Market - Emerging Technological Innovations | Global Industry Growth Dynamics

The report “Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecast to 2023", The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%.

The growth of this market is mainly driven by factors such as the increasing prevalence of chronic diseases, growing company initiatives, and growing adoption of gene panels owing to their benefits such as cost-efficiency and simplified the workflow.

The research and academic institutes segment is projected to grow at the highest CAGR during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101282859

Based on end user, the market is segmented into research & academic institutes, hospital & diagnostic laboratories, and pharmaceutical & biotechnology companies. The research and academic institutes segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing government funding programs across the globe and the focus of market players on providing efficient gene panels.

Target Audience for this Report:

# NGS equipment manufacturers, vendors, and distributors

# NGS sequencing services companies

# NGS bioinformatics/data analysis companies

# Research institutes and government organizations

# Venture capitalists and government funding organizations

# Research and consulting firms

# Healthcare institutions

# Pharmaceutical and biotechnology companies

# Contract manufacturing organizations

# Contract research organizations

North America is expected to dominate the gene panels market in 2018

In 2018, North America is expected to hold the largest share of the gene panels market followed by Europe. The large share of this geographical segment is primarily attributed to the growing research on cancer and inherited rare diseases and the increasing number of NGS-based & clinical applications in the region. Other growth factors include government support for genomics research and the presence of leading NGS providers in this region.

Agreements, partnerships, joint ventures, and collaboration accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=101282859

Some of the key players in the gene panels market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), ), Novogene Corporation (China), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US).

Veterinary PoC Diagnostics Market - Leading Players & Their Contribution to Global Industry Revenue

In 2018, IDEXX Laboratories, Inc. (US) and Zoetis, Inc. (US) dominated the global veterinary point-of-care diagnostics industry, accounting for more than ~80–85% of the total market share.

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Some of the other prominent players operating in the veterinary point-of-care diagnostics market are Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Zoetis, Inc. (US) dominated the global veterinary point-of-care diagnostics market 2018. The company has a diversified product portfolio, which includes a wide range of point-of-care diagnostic products. IDEXX’s position in the market is attributed to its active R&D activities and wide distribution footprint across the world. To garner a larger share of the market, the company continuously focuses on product developments and launches.

Recent Developments:

# In 2019, IDEXX Laboratories launched a Canine Progesterone Test for Catalyst Dx and Catalyst One Chemistry Analyzers.

# In 2019, Zoetis, Inc. launched Stablelab, a handheld point-of-care diagnostic blood test for equine.

# In 2019, FUJIFILM SonoSite partnered with Partners Healthcare (US) to enable clinicians to perform scans at point of care.

# In 2019, Eurolyser partnered with Sysmex Corporation (Japan) to sell Eurolyser’s point of care systems measuring CRP.

IDEXX Laboratories, Inc. (US) accounted for the second-largest share of the veterinary point-of-care diagnostics market in 2018. Its dominance in the market can be attributed to its wide range of product offerings and its strong geographical footprint. In 2018, the company acquired Abaxis, Inc. (US), a pioneer in the veterinary point-of-care diagnostics industry for USD 2.0 billion. The company also focuses on R&D activities to develop its animal health solutions that meet the customers’ demands.

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the global veterinary point-of-care diagnostics market?

# What covers the drivers, restraints, opportunities, and challenges in the veterinary point-of-care diagnostics industry?

# What are the new technological advancements in the veterinary point-of-care diagnostics market?

# Comment on the regulatory scenario for the veterinary point-of-care diagnostics industry in various geographies.

# What are the growth trends in the veterinary point-of-care diagnostics market at the segmental and overall market levels?

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

North America will continue to dominate the market during the forecast period

The market, by region, is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary point-of-care diagnostics market in 2018. The large share of North America in the global market can be attributed to the increasing adoption of companion animals, growing veterinary healthcare expenditure, and rising demand for animal-derived food products.

E-Prescription Systems Industry - Major Leaders & Global Dynamics

MarketsandMarkets forecasts the e-prescribing market to grow from USD 546.5 million in 2016 to USD 1,403.2 million by 2021, at a Compound Annual Growth Rate (CAGR) of 20.8% during the forecast period. The major factors that are expected to be driving the e-prescribing market are the growing volume of patient data; advancements in technological expertise; rising government initiatives & the introduction of incentive programs for the adoption of e-prescribing; and the need for efficiency in healthcare processes.

The objective of the report is to define, describe, and forecast the e-prescribing market size based on product, delivery mode, usability, end user, and region.

The global e-prescribing market is consolidated in nature with the top five market players accounting for more than 60% of the market.

Epic Systems Corporation (U.S.), Cerner Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Quality Systems, Inc. (U.S.), athenahealth, Inc. (U.S.), Medical Information Technology, Inc. (U.S.), and RelayHealth Corporation (U.S.) lead the global e-prescribing market. Some of the other leading players in this market include Henry Schein, Inc. (U.S.), Computer Programs and Systems Inc. (U.S.), DrFirst, Inc. (U.S.), Surescripts-RxHub, LLC (U.S.), Change Healthcare Holdings, Inc. (U.S.), Practice Fusion, Inc. (U.S.), GE Healthcare (U.S.), and eClinicalworks (U.S.).

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=910

Epic Systems Corporation is a leading provider of e-prescribing solutions, specializes in interoperable solutions, and mainly focuses on the needs of mid-sized to large hospitals and integrated healthcare organizations. The company is notable for having secured more contracts with hospitals in 2014 than any of its competitors in this market.

It also—along with athenahealth—did not lose any existing customers in that year. Its customers include U.S.-based hospital chains such as Johns Hopkins Health System, Duke University Health System, UNC Health Care, University of Utah Health Care, and Vanderbilt Health System.

Cerner Corporation is one of the major players in the global e-prescribing market. Cerner mainly focuses on acquisitions as its key business strategy. In line with this strategy, in February 2015, Cerner acquired Siemens Health Services (Germany) and its assets, client relationships, and associates. Furthermore, in December 2014, the company acquired InterMedHx, LLC (U.S.) a provider of health technology solutions in the areas of preventive care, patient administration, and medication history.

This acquisition strengthened Cerner‘s e-prescribing and other healthcare IT business. Cerner Corporation also focuses on expanding its business globally to strengthen its position in the e-prescribing market, particularly in high-growth regions such as Asia-Pacific and Latin America. Currently, the geographic segments of Europe and North America account for about 90% of the company‘s e-prescribing business.

While Cerner is able to compete for major contracts within the U.S., it has also seen significant growth in the U.K., the Middle East, and Australia. Furthermore, the company has a strong product portfolio for e-prescribing, including e-prescribing solutions, ambulatory EHR, networking services, and standalone solutions.

Allscripts Healthcare Solutions Inc. is one of the major players in the e-prescribing and electronic health record market. It is a research-based HCIT company that provides innovative clinical software and services that deliver significant benefits to patients and healthcare professionals. The company focuses on R&D activities to enhance its service offerings. In 2015, the company invested USD 234.1 million—about 17% of its total revenue—on R&D activities.

The company expanded considerably in April 2016 post its merger with Netsmart Technologies, Inc. (U.S.). Another factor contributing to the major share of the company is its agreement with CoverMyMeds for the Allscripts eAuth software, to enable prescription providers to quickly authorize prescriptions electronically. CoverMyMeds is the largest electronic prior authorization (ePA) platform in the U.S., providing connectivity that impacts as much as 72% of all prescriptions circulated electronically in the country

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=910

The key strategies adopted by major players in the global e-prescribing market are agreements, partnerships & collaborations; mergers & acquisitions; product launches; and geographic expansions. In this competitive market, global players aim to maintain their market position through continuous investments in R&D with a focus on developing innovative solutions or enhancing their existing solutions.

Laboratory Centrifuge Market is Expecting Major Makeover in Near Future

The study involved four major activities to estimate the current market size for laboratory centrifuge market. Exhaustive secondary research was done to collect information on market, peer market, and parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the laboratory centrifuge market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# Laboratory centrifuges revenue generated by the leading players have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

Asia to grow at the highest CAGR during the forecast period

The laboratory centrifuges market has been segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW). Currently, North America dominates the global laboratory centrifuges market, and this trend is expected to continue during the forecast period. However, the market in Asia is estimated to grow at the highest CAGR during the forecast period. The presence of emerging economies such as China and India and the increasing R&D investments by pharmaceutical and biotechnology companies in this region are the major factors supporting the growth of the Asian laboratory centrifuges market.

Key Questions addressed by this report:

# Where will all these developments take the industry in the mid to long term?

# Which are the key players in the market and how intense is the competition?

# Which are the recent contracts and agreements key players have signed?

Key players in the laboratory centrifuges market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), Sigma Laborzentrifugen GmbH (Germany), Andreas Hettich GmbH & Co. KG (Germany), Kubota Corporation (Japan), Koki Holdings Co., Ltd. (Japan) (previously Hitachi Koki Co., Ltd.), QIAGEN N.V. (Netherlands), NuAire (US), Sartorius (Germany), HERMLE Labortechnik GmbH (Germany), and Becton, Dickinson and Company (US).

These players have adopted various growth strategies, such as partnerships, agreements, and collaborations; and new product launches, to further expand their presence in the laboratory centrifuges market. 

Product launches have been the key growth strategies adopted players from 2016 to 2018, which helped them to innovate on their offerings and broaden their customer base. Some of the leading players who adopted this strategy include Thermo Fisher Scientific Inc. (US), Eppendorf AG (Germany), and Danaher Corporation (US).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

Active Pharmaceutical Ingredient Industry - Major Leaders and Their Contribution to Global Revenue

The study involved four major activities to estimate the current size of the global active pharmaceutical ingredient market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global active pharmaceutical ingredient market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The revenue generated from the sale of active pharmaceutical ingredients by leading players has been determined through primary and secondary research.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263

The global APIs market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market.

Acquisitions and collaborations have been the key growth strategies adopted by players from 2016 to 2018.

Some of the leading players who adopted these strategies include Pfizer, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), and Bristol-Myers Squibb (US).

Key Questions addressed by the report:

# Where will all these developments take the industry in the mid to long term?

# What types of annual and multi-year partnerships are API companies exploring?

# Which are the key players in the market and how intense is the competition?

# Which are the recent contracts and agreements key players have signed?

# What are the recent trends affecting the API manufacturers?

Pfizer is one of the leading players in the APIs market. The leading position of the company is majorly attributed to its exhaustive product portfolio. The company has a strong brand image, which gives it a competitive edge over other players. In order to remain competitive and strengthen its market position, the company primarily focuses on adopting both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product approvals, and acquisitions.

Novartis is another leading player in the APIs market. Its leading position can be attributed to its strong brand recognition and robust product portfolio. In order to maintain its leading position, the company invests a significant amount of its revenue in R&D activities. The significant investment in R&D enables the company to launch innovative and technologically advanced products in the market.

Recent Developments:

# In January 2018, Pfizer entered into a collaboration with Sangamo Therapeutics, Inc. (US) for the development of a potential gene therapy to treat amyotrophic lateral sclerosis (ALS).

# In May 2018, Novartis acquired AveXis, a clinical-stage gene therapy company, to develop a gene-based treatment for spinal muscular atrophy.

# In January 2018, Sanofi acquired Ablynx, a biopharmaceutical company to strengthen its platform for growth in rare blood disorders.

# In January 2018, Sanofi and Alnylam Pharmaceuticals, Inc. (US) announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize the development and commercialization of products prescribed for the treatment of rare genetic diseases.

Sanofi is one of the top players in the global APIs market. The leading position of the company is majorly attributed to its exhaustive product portfolio. The company manufactures APIs through its Sanofi Active Ingredient Solutions portfolio, which provides custom synthesis and API contract manufacturing services. The company pursues various growth strategies to strengthen its position in the APIs market. For instance, in July 2016, Sanofi Pasteur, a business unit of Sanofi, entered into an agreement with the Walter Reed Army Institute of Research (WRAIR) (US) to develop the Zika vaccine.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=263

Boehringer Ingelheim is one of the leading players in the global APIs market. Boehringer Ingelheim’s leading position in the APIs market can be attributed to its exhaustive product portfolio. The company is focused on developing innovative therapies to prolong patient’s lives. Its Prescription Medicines segment is engaged in the development and launch of APIs. In order to remain competitive and further strengthen its market position, the company adopts and implements organic and inorganic growth strategies, such as agreements, partnerships, approvals, alliances, and collaborations.

Bristol-Myers Squibb is a prominent player in the APIs market and holds expertise in the area of pharmaceutical ingredients. The company has a broad product portfolio in biologics, which serves as an important factor for its future growth, especially in the biopharmaceuticals market. In order to maintain its leadership position in the market, the company focuses on growth strategies, such as partnerships and expansions.